40 GUEST STREET, BOSTON, MA
Lucinda Warren Appointed Interim CEO; Usman Azam Resigns
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Other Events
Lucinda Warren Appointed Chief Financial and Business Officer at Cue Biopharma
Announces Pricing of $10 Million Public Offering
Investor Presentation
Departure of Chief Medical Officer Matteo Levisetti Effective November 28, 2025
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence